The Experts below are selected from a list of 12 Experts worldwide ranked by ideXlab platform
W Schmidt - One of the best experts on this subject based on the ideXlab platform.
-
Verbesserung der präoperativen Abklärung von palpablen, nicht-zystischen Prozessen der Mamma durch die Echomammographie*
Ultraschall in Der Medizin, 2008Co-Authors: W Leucht, D Rabe, A Müller, K D Humbert, Dv Fournier, W SchmidtAbstract:Sonographic examination of the female breast has now been generally accepted as a clinical examination method. 1 719 patients were subjected to Echomammography within the framework of a prospective study. Histologically confirmed results were obtained from 496 palpable findings. Basing on these findings, the value of Echomammography was developed in respect of preoperative clarification of palpable carcinomas of the breast. X-ray mammography served as reference method. In benign findings, echomammographic accuracy is 73%, whereas the accuracy of x-ray mammography was found to be 58% only. Fibroadenomas were recognised as a benign process by both methods with an equal quota of accuracy (71% and 73%, respectively). 82% of all fibrocystic mastopathy findings which could be localised via palpation, were sonographically graded as benign, whereas mammography classified only 49% as benign cases. This difference is statistically significant (p less than 0.001). Palpable carcinomas wee considered to be malignant via sonography in 91% of the cases (179 out of 197), whereas x-ray mammography yielded a rate of 82% only. The intraoperative T1 stage was established by sonography in 85% of the palpable carcinomas, whereas x-ray mammography yielded a figure of 76% only. These results underline the importance of Echomammography in preoperative clarification of palpable carcinomas of the breast.
W Leucht - One of the best experts on this subject based on the ideXlab platform.
-
Verbesserung der präoperativen Abklärung von palpablen, nicht-zystischen Prozessen der Mamma durch die Echomammographie*
Ultraschall in Der Medizin, 2008Co-Authors: W Leucht, D Rabe, A Müller, K D Humbert, Dv Fournier, W SchmidtAbstract:Sonographic examination of the female breast has now been generally accepted as a clinical examination method. 1 719 patients were subjected to Echomammography within the framework of a prospective study. Histologically confirmed results were obtained from 496 palpable findings. Basing on these findings, the value of Echomammography was developed in respect of preoperative clarification of palpable carcinomas of the breast. X-ray mammography served as reference method. In benign findings, echomammographic accuracy is 73%, whereas the accuracy of x-ray mammography was found to be 58% only. Fibroadenomas were recognised as a benign process by both methods with an equal quota of accuracy (71% and 73%, respectively). 82% of all fibrocystic mastopathy findings which could be localised via palpation, were sonographically graded as benign, whereas mammography classified only 49% as benign cases. This difference is statistically significant (p less than 0.001). Palpable carcinomas wee considered to be malignant via sonography in 91% of the cases (179 out of 197), whereas x-ray mammography yielded a rate of 82% only. The intraoperative T1 stage was established by sonography in 85% of the palpable carcinomas, whereas x-ray mammography yielded a figure of 76% only. These results underline the importance of Echomammography in preoperative clarification of palpable carcinomas of the breast.
Hassan Errihani - One of the best experts on this subject based on the ideXlab platform.
-
Neuro Endocrine Breast Tumor: Primary or Secondary Tumor? Case Report and Review of the Litterature
Journal of Clinical Case Reports, 2018Co-Authors: Adil Debbagh, Mohamed Allaoui, Alaoui Slimani K, Sbitti Y, Bennani F, Mohamed Ichou, Hassan ErrihaniAbstract:Background: Neuroendocrine breast tumors may be primary or secondary with a fairly rare frequency; The diagnosis is based on the results of the pathological findings and the characterization between the primary and secondary origin is guided by the data of radiology (Echomammography), the pathological and immunohistochemistry examinations as well as the data reported by the octreoscanner. Case presentation: We describe here a case of a 70-year-old patient who had a dorsal pain for six months. A Scan of rachis showed a tumoral process of the vertebral body of D2 extending intramedullarily. The realization of a thoraco abdomino-pelvic CT scan as part of an assessment of extension, revealed the presence of a left mammary nodule with diffuse liver metsatases. Liver and breast biopsy evoking a localization of a neuroendorin tumor. Conclusion: This presentation reveals that the Differentiation between primary or secondary neuro endocrine breast tumor is based on the results of the pathological, immunohistochemical findings and radiological characteristics. In the absence of a generalized metastatic disease, the treatment is similar to Invasive breast tumors, under metastasis conditions. The treatment consists of various therapetical modalities including chemotherapy, hormonotherapy targeted therapies.
K D Humbert - One of the best experts on this subject based on the ideXlab platform.
-
Verbesserung der präoperativen Abklärung von palpablen, nicht-zystischen Prozessen der Mamma durch die Echomammographie*
Ultraschall in Der Medizin, 2008Co-Authors: W Leucht, D Rabe, A Müller, K D Humbert, Dv Fournier, W SchmidtAbstract:Sonographic examination of the female breast has now been generally accepted as a clinical examination method. 1 719 patients were subjected to Echomammography within the framework of a prospective study. Histologically confirmed results were obtained from 496 palpable findings. Basing on these findings, the value of Echomammography was developed in respect of preoperative clarification of palpable carcinomas of the breast. X-ray mammography served as reference method. In benign findings, echomammographic accuracy is 73%, whereas the accuracy of x-ray mammography was found to be 58% only. Fibroadenomas were recognised as a benign process by both methods with an equal quota of accuracy (71% and 73%, respectively). 82% of all fibrocystic mastopathy findings which could be localised via palpation, were sonographically graded as benign, whereas mammography classified only 49% as benign cases. This difference is statistically significant (p less than 0.001). Palpable carcinomas wee considered to be malignant via sonography in 91% of the cases (179 out of 197), whereas x-ray mammography yielded a rate of 82% only. The intraoperative T1 stage was established by sonography in 85% of the palpable carcinomas, whereas x-ray mammography yielded a figure of 76% only. These results underline the importance of Echomammography in preoperative clarification of palpable carcinomas of the breast.
Dv Fournier - One of the best experts on this subject based on the ideXlab platform.
-
Verbesserung der präoperativen Abklärung von palpablen, nicht-zystischen Prozessen der Mamma durch die Echomammographie*
Ultraschall in Der Medizin, 2008Co-Authors: W Leucht, D Rabe, A Müller, K D Humbert, Dv Fournier, W SchmidtAbstract:Sonographic examination of the female breast has now been generally accepted as a clinical examination method. 1 719 patients were subjected to Echomammography within the framework of a prospective study. Histologically confirmed results were obtained from 496 palpable findings. Basing on these findings, the value of Echomammography was developed in respect of preoperative clarification of palpable carcinomas of the breast. X-ray mammography served as reference method. In benign findings, echomammographic accuracy is 73%, whereas the accuracy of x-ray mammography was found to be 58% only. Fibroadenomas were recognised as a benign process by both methods with an equal quota of accuracy (71% and 73%, respectively). 82% of all fibrocystic mastopathy findings which could be localised via palpation, were sonographically graded as benign, whereas mammography classified only 49% as benign cases. This difference is statistically significant (p less than 0.001). Palpable carcinomas wee considered to be malignant via sonography in 91% of the cases (179 out of 197), whereas x-ray mammography yielded a rate of 82% only. The intraoperative T1 stage was established by sonography in 85% of the palpable carcinomas, whereas x-ray mammography yielded a figure of 76% only. These results underline the importance of Echomammography in preoperative clarification of palpable carcinomas of the breast.
